O'Neil Global Advisors, Inc. Medpace Holdings, Inc. Transaction History

O'Neil Global Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$372.0 - $424.34 $7,068 - $8,062	19 Added 3.45%	570 $235,000
Q1 2024 May 10, 2024	SELL	$284.87 - $413.31 $41,021 - $59,516	-144 Reduced 20.72%	551 $223,000
Q4 2023 Feb 09, 2024	BUY	$227.52 - $312.68 $158,126 - $217,312	695 New	695 $213,000
Q2 2023 Aug 11, 2023	SELL	$187.26 - $240.17 $199,431 - $255,781	-1,065 Closed	0 $0
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $199,431 - $255,781	1,065 New	1,065 $256,000
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $814,585 - $1.21 Million	5,322 New	5,322 $1.13 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of O'Neil Global Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on O'Neil Global Advisors, Inc. with notifications on news.